National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

PNP-expressing ovine atadenovirus FP253
An ovine atadenovirus encoding E. coli purine nucleoside phosphorylase (PNP) with prodrug activating activity. Under the control of a prostate-directed promoter, PNP-expressing atadenovirus vaccine FP253 expresses PNP in prostate tissue only after intraprostatic administration; this enzyme catalyzes systemically administered fludarabine prodrug into the active agent, 2-fluoroadenine. Localized prodrug activation provides prostate-targeted chemotherapy, potentially reducing systemic side effects. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Code name:FP253



Previous:plitidepsin, pneumococcal polyvalent vaccine, Pneumovax 23, pNGVL3-hICD vaccine, pNGVL4a-Sig/E7(detox)/HSP70 DNA vaccine
Next:Pnu-Imune 23, polifeprosan 20 with carmustine implant, Polo-like kinase 1 inhibitor GSK-461364, Polo-like kinase 1 inhibitor ON 01910.Na, poly AU

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov